Concepedia

Alexia Tellier

AT

Statistics

Publications

3

Citations

1.5K

H-Index

3

Active since

2012

Affiliations

Sanofi (France)(Current)

Alexia Tellier is an author at Sanofi (France) specializing in oncology, pharmacology, and medicine.

Publications per year

2012–2020

3

Publications

3

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Eric Van Cutsem, Josep Tabernero, Radek Lakomý et al. · Journal of Clinical Oncology · 2012 · 1.4K citations

, , +15

A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870).

Carlos Gomez‐Roca, Valentina Boni, Víctor Moreno et al. · Journal of Clinical Oncology · 2016 · 38 citations

, , +14

An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities

Céline Nicolazzi, Anne Caron, Alexia Tellier et al. · Molecular Cancer Therapeutics · 2020 · 32 citations

, , +17

1–3 of 3